Associate Professor, Internal Medicine, University of Virginia School of Medicine
Infectious Disease
Dr. Eric R. Houpt, MD
|
|
Give Review
Eric Houpt is an expert in the field of Infectious Disease. He went to medical school at Emory University School of Medicine. Emory University School of Medicine has a rank of 23 in research and a 42 in primary care He over the years received 12 awards: "Oswald Avery Award", "Deans Excellence in Research Award", "Centers of Excellence in Translational Research Study Section", "Deans Excellence in Teaching Award", "Academy of Distinguished Educators", "Academic Faculty Teaching Award", "Elected Member", "Bailey K. Ashford medal", "Award for Excellence in Research", "Junior Faculty Award", "Basic Career Development Award" and "Wyeth-Lederle Vaccines Young Investigator Award in Infectious Diseases". Eric R. Houpt, MD is a published doctor. He has 97 papers published. The most current publication "Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia." He accepts all Medicare patients.
Publications
- Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
- Sensititre MycoTB Plate Compared to Bactec MGIT 960 for First- and Second-Line Antituberculosis Drug Susceptibility Testing in Tanzania: a Call To Operationalize MICs.
- Comparison and development of pyrazinamide susceptibility testing methods for tuberculosis in Thailand.
- Development of a TaqMan Array Card for Acute Febrile Illness Outbreak Investigation and Surveillance of Emerging Pathogens including Ebola Virus.
- Molecular genotyping and quantitation assay for rotavirus surveillance.
- Kinetics of polio shedding following oral vaccination as measured by qRT-PCR versus culture.
- Methods of Analysis of Enteropathogen Infection in the MAL-ED Cohort Study.
- Correlation between Diarrhea Severity and Oocyst Count via Quantitative PCR or Fluorescence Microscopy in Experimental Cryptosporidiosis in Calves.
- A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.
- Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis.
- Campylobacter detection and significance in stool by culture, enzyme immunoassay, and PCR in developing country settings.
- Pre-earthquake non-epidemic Vibrio cholerae in Haiti.
- Calcified Neurocysticercus, Perilesional Edema, and Histologic Inflammation.
- Hemolytic Uremic Syndrome following O111 Shiga toxin producing E. coli revealed through molecular diagnostics.
- Discordance across Several Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Single Laboratory.
- Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.
- Association Between Stool Enteropathogen Quantity and Disease in Tanzanian Children Using TaqMan Array Cards: A Nested Case-Control Study.
- Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis.
- Rapid detection of pyrazinamide resistant Mycobacterium tuberculosis by high resolution melting curve analysis.
- Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation.
- Etiology of Diarrhea in Bangladeshi Infants in the First Year of Life Using Molecular Methods.
- New concepts in diagnostics for infectious diarrhea.
- Enteroaggregative Escherichia coli quantification in children stool samples using quantitative PCR.
- Quantitative PCR for detection of Shigella improves ascertainment of Shigella burden in children with moderate-to-severe diarrhea in low-income countries.
- Diagnosis and interim treatment outcomes from the first cohort of multidrug-resistant tuberculosis patients in Tanzania.
- 18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series.
- Digital PCR to Detect and Quantify Heteroresistance in Drug Resistant Mycobacterium tuberculosis.
- The Effect of the Leptin Receptor Q223R Polymorphism on the Host Transcriptome Following Infection with E. histolytica.
- Gut microbiomes of Malawian twin pairs discordant for kwashiorkor.
- A Laboratory Developed TaqMan Array Card for Simultaneous Detection of Nineteen Enteropathogens.
- Diagnostic Microbiologic Methods in the GEMS-1 Case/Control Study.
- Disruption of the human gut microbiota following Norovirus infection.
- Entamoeba moshkovskii is associated with diarrhea in infants and causes diarrhea and colitis in mice.
- The future of molecular diagnostics for drug-resistant tuberculosis.
- Comparison of overnight pooled and standard sputum collection method for patients with suspected pulmonary tuberculosis in northern Tanzania.
- Precaution for using nucleic Acid-based methods to detect Aeromonas.
- Development of a multiplex polymerase chain reaction assay for diarrheagenic Escherichia coli and Shigella spp. and its evaluation on colonies, culture broths, and stool.
- Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.
- Dual probe DNA capture for sensitive real-time PCR detection of Cryptosporidium and Giardia.
- Molecular Techniques in Ecohealth Research Toolkit: Facilitating Estimation of Aggregate Gastroenteritis Burden in an Irrigated Periurban Landscape.
- Molecular Diagnosis of Diarrhea: Current Status and Future Potential.
- Simultaneous detection of six diarrhea-causing bacterial pathogens with an in house PCR-Luminex Assay.
- Multiplex polymerase chain reaction method to detect Cyclospora, Cystoisospora, and Microsporidia in stool samples.
- A plasma drug activity assay for treatment optimization in tuberculosis patients.
- Defining the causes of diarrhea: novel approaches.
- Optimizing second-line therapy for drug-resistant tuberculosis: the additive value of sequencing for multiple resistance Loci.
- A mutation in the leptin receptor is associated with Entamoeba histolytica infection in children.
- Efficacy of antiamebic drugs in a mouse model.
- Multiplex reverse transcription PCR Luminex assay for detection and quantitation of viral agents of gastroenteritis.
- High throughput multiplex PCR and probe-based detection with Luminex beads for seven intestinal parasites.
- Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.
- Entamoeba histolytica infection and secreted proteins proteolytically damage enteric neurons.
- Therapeutic drug monitoring for slow response to tuberculosis treatment in a state control program, Virginia, USA.
- A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target.
- The NF-kappaB p50 subunit is protective during intestinal Entamoeba histolytica infection of 129 and C57BL/6 mice.
- Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut.
- Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.
- Giardia intestinalis assemblages A and B infections in Nepal.
- Rapid Diagnosis of Intestinal Parasitic Protozoa, with a Focus on Entamoeba histolytica.
- Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh.
- Gender and genetic control of resistance to intestinal amebiasis in inbred mice.
- Giardia duodenalis assemblage, clinical presentation and markers of intestinal inflammation in Brazilian children.
- Entamoeba histolytica: genetic diversity of African strains based on the polymorphism of the serine-rich protein gene.
- Entamoeba histolytica phagocytosis of human erythrocytes involves PATMK, a member of the transmembrane kinase family.
- Crosstalk at the initial encounter: interplay between host defense and ameba survival strategies.
- Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction.
- Multiplex real-time PCR assay for detection of Entamoeba histolytica, Giardia intestinalis, and Cryptosporidium spp.
- Three domains of competency in global health education: recommendations for all medical students.
- Cryptosporidium species: preliminary descriptions of the prevalence and genotype distribution among school children and hospital patients in the Venda region, Limpopo...
- Prevalence and species distribution of E. Histolytica and E. Dispar in the Venda region, Limpopo, South Africa.
- Resistance of C57BL/6 mice to amoebiasis is mediated by nonhemopoietic cells but requires hemopoietic IL-10 production.
- Impact of intestinal colonization and invasion on the Entamoeba histolytica transcriptome.
- Adherence-blocking vaccine for amebiasis.
- Giardia assemblage A infection and diarrhea in Bangladesh.
- Global impact of diarrheal diseases that are sampled by travelers: the rest of the hippopotamus.
- Short report: asymptomatic Cryptosporidium hominis infection among human immunodeficiency virus-infected patients in Tanzania.
- Resistance to intestinal Entamoeba histolytica infection is conferred by innate immunity and Gr-1+ cells.
- Multiplex real-time PCR assay using Scorpion probes and DNA capture for genotype-specific detection of Giardia lamblia on fecal samples.
- Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
- The mouse model of amebic colitis reveals mouse strain susceptibility to infection and exacerbation of disease by CD4+ T cells.
- The mucosal immune response in a mouse model of amebic colitis.
- In vitro and in vivo interaction of Entamoeba histolytica Gal/GalNAc lectin with various target cells: an immunocytochemical analysis.
- Mycobacterial infections in a large Virginia hospital, 2001-2009.
- Cryptosporidium parvum bovine genotype oocysts in the respiratory samples of an AIDS patient: efficacy of treatment with a combination of azithromycin and paromomycin.
- Real-time PCR detection and speciation of Cryptosporidium infection using Scorpion probes.
- CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine.
- Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania.
- IMS-free DNA extraction for the PCR-based quantification of Cryptosporidium parvum and Giardia lamblia in surface and waste water.
- High prevalence of Entamoeba moshkovskii in a Tanzanian HIV population.
- Technology in global health: the need for essential diagnostics.
- Infection risk assessment of diarrhea-related pathogens in a tropical canal network.
- Persistence of Entamoeba histolytica infection in CBA mice owes to intestinal IL-4 production and inhibition of protective IFN-gamma.
- Leptin signaling in intestinal epithelium mediates resistance to enteric infection by Entamoeba histolytica.
- Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis.
- Caspase 3-dependent killing of host cells by the parasite Entamoeba histolytica.
- Early Therapeutic Drug Monitoring for Isoniazid and Rifampin among Diabetics with Newly Diagnosed Tuberculosis in Virginia, USA.
Schools
Emory University School Of Medicine
University of Chicago
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Awards
- Oswald Avery Award
- Dean’s Excellence in Research Award
- Centers of Excellence in Translational Research Study Section
- Dean’s Excellence in Teaching Award
- Academy of Distinguished Educators
- Academic Faculty Teaching Award
- Elected Member
- Bailey K. Ashford medal
- Award for Excellence in Research
- Junior Faculty Award
- Basic Career Development Award
- Wyeth-Lederle Vaccines Young Investigator Award in Infectious Diseases
Education
-
Emory University School of Medicine
Drug Facts
| NPI NUMBER | 1720157332 | |
| NPPES Provider LastName | HOUPT | |
| NPPES Provider FirstName | ERIC | |
| NPPES Provider ZIPCode | 229080001 | |
| NPPES Provider State | VA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 12.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1720157332 |
| Last Name Of The Provider | HOUPT |
| First Name Of The Provider | ERIC |
| View All |
Similar Doctors
|
Dr. Edward H. Oldfield, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Rebecca A. Dillingham, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gerald R. Donowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frederick G. Hayden, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joshua Eby, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard L. Guerrant, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. William A. Petri, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
Dr. Richard D. Pearson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ronald B. Turner, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Amy J. Mathers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tania A. Thomas, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory C. Townsend, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Dean H. Kedes, MD |
|
|
Dr. Leigh B. Grossman, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Costi Sifri, MD
This Doctor is OpenDoctor Recommended.
|